Blinatumomab, CAS 853426-35-4

Product Description: Blinatumomab (Anatumomab) is a bispecific monoclonal antibody which can specifically targets the CD19 antigen present on B cells. Blinatumomab can be used for the research of acute lymphoblastic leukemia[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Kantarjian H, et, al. Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia. N Engl J Med. 2017 Mar 2;376(9):836-847.

CAS Number: 853426-35-4

Molecular Weight: N/A

Compound Purity: 98.78

Research Area: Cancer

Solubility: H2O

Target: CD19

• SKU: MEXHY-P9963-100UG
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P9963-100UG
• Package Unit: 100 μg
• Quantity Unit: STK
• Conjugate: Unconjugated